P01-050 – Anakinra in systemic JIA: single center experience
نویسندگان
چکیده
منابع مشابه
P01-050 – Anakinra in systemic JIA: single center experience
Introduction Systemic juvenile idiopathic arthritis (sJIA) accounts for 10-20% of all patients with JIA. The clinical features include fever, evanescent rash, arthralgia and arthritis, myalgia, lymphadenopathy, hepatomegaly, splenomegaly and serositis. Interleukin 1 (IL-1) has been shown to be a major mediator of the inflammatory cascade that underlies sJIA (1). Treatment with anakinra, IL-1 re...
متن کاملP01-049 – Assessment of vascular function in systemic JIA
Methods Eighteen patients ( 12 males, 6 females) with diagnosis of SoJIA according to the International League of Associations for Rheumatology criteria were compared to 75 ageand sex-matched controls. No participant was overweight, obese, or had a history of hypertension, dyslipidemia, diabetes mellitus, or cardiovascular disease. Arterial stiffness (As) was evaluated by measurement of carotid...
متن کاملP01-048 – Systemic onset JIA with coronary artery dilation
Case Report A 2-year old boy had been treated as incomplete KD by 2 gr/kg/day of IVIG and 80 mg/kg/day of aspirin at a general pediatrics clinic. From his previous data it was learned that, fever was present for 24 days and it was peaking two to three times a day. He had had a faint rash, arthralgia and lymphadenopathy during follow-up period. But he had’t got conjuctivitis or extremity changes...
متن کاملP01-031 – Anakinra for colchicine resistant FMF
Methods We plan to include patients, agreeing with clinical and genetic diagnosis of FMF, who suffer from FMF attacks, at least once per month, in one of the sites commonly involved by FMF (Chest, abdomen, lower extremity large joints, and skin), despite treatment with colchicine 2 mg/ day or less (in case of colchicine intolerance). Involvement with other diseases relevant (vasculitis, spondyl...
متن کاملAnakinra treatment in patients with Familial Mediterranean Fever: a single-center experience
Results There were 36 FMF patients with FMF who were treated with anakinra for various indications (amyloidosis in 11, colchicine resistant recurrent febrile attacks in 21, colchicine related side effects in 4). Two patients were excluded since they have been on anakinra for less than one month (one with amyloidosis, one pregnant). The mean age of the group was 34.8±10.8 years. The mean duratio...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Pediatric Rheumatology
سال: 2013
ISSN: 1546-0096
DOI: 10.1186/1546-0096-11-s1-a53